Cargando…
m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma
N6-methyladenosine (m6A) RNA methylation has been shown to have prognostic value in cancer. Nonetheless, its potential role regarding immunity, metabolism, and stemness in soft tissue sarcoma (STS) remains unknown. We comprehensively estimated the m6A modification patterns and corresponding immunity...
Autores principales: | Huang, Zhen-Dong, Lin, Lu-Lu, Liu, Zi-Zhen, Hu, Chao, Gu, Hui-Yun, Wei, Ren-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739240/ https://www.ncbi.nlm.nih.gov/pubmed/35003079 http://dx.doi.org/10.3389/fimmu.2021.765723 |
Ejemplares similares
-
m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma
por: Huang, Zhen-Dong, et al.
Publicado: (2022) -
Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas
por: Qi, Lin, et al.
Publicado: (2022) -
Stemness Subtypes and Scoring System Predict Prognosis and Efficacy of Immunotherapy in Soft Tissue Sarcoma
por: Gu, Hui-Yun, et al.
Publicado: (2022) -
Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2022) -
Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma
por: Lin, Lu-Lu, et al.
Publicado: (2021)